应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
NVS 诺华
已收盘 01-13 16:00:00 EST
141.61
-0.21
-0.15%
盘后
141.50
-0.11
-0.08%
19:59 EST
最高
142.59
最低
140.80
成交量
210.71万
今开
142.37
昨收
141.82
日振幅
1.27%
总市值
2,741亿
流通市值
2,611亿
总股本
19.36亿
成交额
2.99亿
换手率
0.11%
流通股本
18.44亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
FDA概述细胞/基因疗法CMC灵活性 可能对诺华与辉瑞有利
环球市场播报 · 00:01
FDA概述细胞/基因疗法CMC灵活性 可能对诺华与辉瑞有利
赛诺神经与诺华签署17亿美元许可协议 合作开发阿尔茨海默病治疗药物
环球市场播报 · 01-12 23:24
赛诺神经与诺华签署17亿美元许可协议 合作开发阿尔茨海默病治疗药物
中晟全肽与诺华就一款放射性配体疗法资产签署全球授权协议
每日经济新闻 · 01-12 16:15
中晟全肽与诺华就一款放射性配体疗法资产签署全球授权协议
超1亿美元！蛋白降解剂“吸金”，强生、诺华、谷歌都来了
医药魔方 · 01-09
超1亿美元！蛋白降解剂“吸金”，强生、诺华、谷歌都来了
千亿美元“专利悬崖”逼近！美股制药巨头瞄准收购新药，中小盘生物科技股迎来“超级溢价”投资盛宴？
智通财经 · 01-09
千亿美元“专利悬崖”逼近！美股制药巨头瞄准收购新药，中小盘生物科技股迎来“超级溢价”投资盛宴？
特朗普标榜“大胜”：九大药企达成降价协议换取三年关税豁免
华尔街见闻 · 2025-12-20
特朗普标榜“大胜”：九大药企达成降价协议换取三年关税豁免
默沙东(MRK.US)、施贵宝(BMY.US)等多家药企同意下调美国药价 以换取特朗普政府关税豁免和政策支持
智通财经 · 2025-12-20
默沙东(MRK.US)、施贵宝(BMY.US)等多家药企同意下调美国药价 以换取特朗普政府关税豁免和政策支持
美国官员称与安进、施贵宝、罗氏旗下基因泰克、吉利德、葛兰素史克、默沙东、诺华、赛诺菲和博瑞诺的交易
美股速递 · 2025-12-20
美国官员称与安进、施贵宝、罗氏旗下基因泰克、吉利德、葛兰素史克、默沙东、诺华、赛诺菲和博瑞诺的交易
中国同辐(01763)附属原子高科与诺华公司签署商业合作协议
智通财经 · 2025-12-15
中国同辐(01763)附属原子高科与诺华公司签署商业合作协议
美股异动丨诺华制药盘前涨近2%，布局过敏性疾病新靶点
格隆汇 · 2025-12-09
美股异动丨诺华制药盘前涨近2%，布局过敏性疾病新靶点
诺华制药(NVS.US)17亿美元押注英国AI药企 布局过敏性疾病新靶点
智通财经 · 2025-12-09
诺华制药(NVS.US)17亿美元押注英国AI药企 布局过敏性疾病新靶点
大摩：将诺华制药目标价上调至115瑞士法郎
中金财经 · 2025-12-03
大摩：将诺华制药目标价上调至115瑞士法郎
诺华慢性自发性荨麻疹创新药物瑞普多（瑞米布替尼片）在华获批
南方财经网 · 2025-11-26
诺华慢性自发性荨麻疹创新药物瑞普多（瑞米布替尼片）在华获批
诺华计划2027年底前在瑞士裁员550人
格隆汇 · 2025-11-25
诺华计划2027年底前在瑞士裁员550人
诺华中国回应解散县域团队传闻
南方财经网 · 2025-11-25
诺华中国回应解散县域团队传闻
诺华同意收购RNA疗法创新企业Avidity Biosciences，以强化其后期阶段的神经科学管线
动脉网 · 2025-11-25
诺华同意收购RNA疗法创新企业Avidity Biosciences，以强化其后期阶段的神经科学管线
美国FDA批准诺华基因疗法治疗罕见肌肉疾病
格隆汇 · 2025-11-25
美国FDA批准诺华基因疗法治疗罕见肌肉疾病
诺华制药预计2030年销售增长至多6%，上调主要癌症药物销售预测
格隆汇 · 2025-11-20
诺华制药预计2030年销售增长至多6%，上调主要癌症药物销售预测
诺华(NVS)拟在美国北卡罗来纳州新建制造中心
金吾财讯 · 2025-11-20
诺华(NVS)拟在美国北卡罗来纳州新建制造中心
诺华制药(NVS.US)上调两大抗癌药销售峰值预测 预计推动2030年前营收年均增长5%-6%
智通财经 · 2025-11-20
诺华制药(NVS.US)上调两大抗癌药销售峰值预测 预计推动2030年前营收年均增长5%-6%
加载更多
公司概况
公司名称：
诺华
所属市场：
NYSE
上市日期：
--
主营业务：
Novartis AG于1996年2月29日在瑞士成立。该公司是一家创新药物公司，从事各种创新药物的研究、开发、制造、分销、营销和销售。该公司的宗旨是利用其科学专业知识寻找治疗和治愈疾病的新方法，重新构想医学，以改善和延长人们的生命。该公司的业务分为五个组织部门：生物医学研究、开发、运营和两个商业部门（美国和国际）。全球职能部门支持这些组织部门开展工作。该公司专注于四个具有强大增长潜力和大量未满足患者需求的核心治疗领域—心血管、肾脏和代谢；免疫学；神经科学；和肿瘤学。
发行价格：
--
{"stockData":{"symbol":"NVS","market":"US","secType":"STK","nameCN":"诺华","latestPrice":141.61,"timestamp":1768338000000,"preClose":141.82,"halted":0,"volume":2107067,"hourTrading":{"tag":"盘后","latestPrice":141.5,"preClose":141.61,"latestTime":"19:59 EST","volume":40386,"amount":5720754.9754,"timestamp":1768352344146},"delay":0,"floatShares":1843882545,"shares":1935853188,"eps":7.299003,"marketStatus":"已收盘","change":-0.21,"latestTime":"01-13 16:00:00 EST","open":142.37,"high":142.59,"low":140.795,"amount":298786061.88596004,"amplitude":0.012657,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":7.299003,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1768381200000},"marketStatusCode":5,"adr":1,"adrRate":1,"exchange":"NYSE","adjPreClose":141.82,"dividendRate":0.027275,"preHourTrading":{"tag":"盘前","latestPrice":142.42,"preClose":141.82,"latestTime":"09:29 EST","volume":4217,"amount":600301.04071,"timestamp":1768314599912},"postHourTrading":{"tag":"盘后","latestPrice":141.5,"preClose":141.61,"latestTime":"19:59 EST","volume":40386,"amount":5720754.9754,"timestamp":1768352344146},"volumeRatio":1.112573,"impliedVol":0.2272,"impliedVolPercentile":0.3665},"requestUrl":"/m/hq/s/NVS","defaultTab":"news","newsList":[{"id":"2603691636","title":"FDA概述细胞/基因疗法CMC灵活性 可能对诺华与辉瑞有利","url":"https://stock-news.laohu8.com/highlight/detail?id=2603691636","media":"环球市场播报","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603691636?lang=zh_cn&edition=full","pubTime":"2026-01-14 00:01","pubTimestamp":1768320060,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局（FDA）详细说明了为加速细胞与基因治疗开发而定制的生产与控制让步措施，同时保持标准，这可能对诺华（NVS）和辉瑞（PFE）等开发商构成潜在利好。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：张俊 SF065","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-01-14/doc-inhheupf5646437.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IE00B19Z3581.USD","LU1066053197.SGD","LU0234572021.USD","LU1023059063.AUD","IE00B2B36J28.USD","IE00BBT3K403.USD","SG9999002232.USD","LU1363072403.SGD","LU0170899867.USD","IE00BFTCPJ56.SGD","LU0289739699.SGD","BK4592","SG9999001176.USD","BK4585","LU0306807586.USD","BK4533","IE00BFXG1179.USD","LU0211331839.USD","NVS","IE00B1BXHZ80.USD","SG9999002224.SGD","BK4550","IE00BLSP4452.SGD","SG9999003800.SGD","LU0868494617.USD","BK4568","LU0320765489.SGD","BK4006","LU0882574139.USD","LU1057294990.SGD","LU2237443895.HKD","SG9999013999.USD","LU0456855351.SGD","IE00BLSP4239.USD","LU1894683348.USD","LU2237443465.HKD","LU2237443382.USD","IE0002141913.USD","BK4588","IE00BHPRN162.USD","PFE","IE000M9KFDE8.USD","BK4532","LU0267386448.USD","LU2237443622.USD","IE0002270589.USD","SGXZ57979304.SGD","IE00B4R5TH58.HKD","LU0306806265.USD","LU2746668974.SGD","IE0009355771.USD","LU0971096721.USD","IE00BJT1NW94.SGD","SG9999001176.SGD","LU0321505439.SGD","BK4007","LU0208291251.USD","LU2237443978.SGD","LU1894683264.USD","BK4599","BK4578","BK4534","LU1066051498.USD","LU0321505868.SGD","LU0149725797.USD","SG9999011175.SGD","IE00B19Z3B42.SGD","LU2237443549.SGD","LU0122379950.USD","LU1883839398.USD","BK4581","LU2746668461.USD","LU0985481810.HKD","IE00BJJMRZ35.SGD","LU0225284248.USD","LU0225771236.USD","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","LU0058720904.USD","LU0070302665.USD"],"gpt_icon":0},{"id":"2602640541","title":"赛诺神经与诺华签署17亿美元许可协议 合作开发阿尔茨海默病治疗药物","url":"https://stock-news.laohu8.com/highlight/detail?id=2602640541","media":"环球市场播报","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602640541?lang=zh_cn&edition=full","pubTime":"2026-01-12 23:24","pubTimestamp":1768231440,"startTime":"0","endTime":"0","summary":"生物科技企业赛诺神经制药公司于周一宣布，已与瑞士制药巨头诺华达成一项价值近 17 亿美元的许可协议，双方将合作开发用于治疗阿尔茨海默病的潜在抗体疗法。 通过这项协议，诺华将获得赛诺神经一项核心专有技术的使用权，该技术旨在优化药物向大脑的递送效率。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-01-12/doc-inhhamhf8113709.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4585","NVS","BK4578","LU0208291251.USD","LU0211331839.USD","IE00B2B36J28.USD","IE0009355771.USD","IE00BJJMRZ35.SGD","IE0002141913.USD","BK4532","IE00BJT1NW94.SGD","BK4007","LU0070302665.USD","BK4588","LU0320765489.SGD","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD"],"gpt_icon":0},{"id":"2602592441","title":"中晟全肽与诺华就一款放射性配体疗法资产签署全球授权协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2602592441","media":"每日经济新闻","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602592441?lang=zh_cn&edition=full","pubTime":"2026-01-12 16:15","pubTimestamp":1768205749,"startTime":"0","endTime":"0","summary":"每经AI快讯，湖南中晟全肽生物科技股份有限公司1月12日通过公众号宣布，公司已与诺华就放射性配体疗法领域一款未披露的多肽类资产达成全球授权与合作协议。根据协议，诺华获得该资产的全球独家授权，并将主导后续所有研发及商业化相关工作。根据协议条款，中晟全肽将获得5000万美元首付款，并有资格获得后续研发、监管及销售里程碑付款，同时有权就未来全球净销售额享受分级特许权使用费。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202601123615775823.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601123615775823.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0070302665.USD","IE00BJJMRZ35.SGD","BK4585","BK4532","LU0208291251.USD","LU0320765489.SGD","BK4578","IE0009355771.USD","IE00BFTCPJ56.SGD","LU0211331839.USD","IE00BJT1NW94.SGD","NVS","IE00B4R5TH58.HKD","IE00B2B36J28.USD","BK4588","BK4007","IE0002141913.USD"],"gpt_icon":0},{"id":"2602322575","title":"超1亿美元！蛋白降解剂“吸金”，强生、诺华、谷歌都来了","url":"https://stock-news.laohu8.com/highlight/detail?id=2602322575","media":"医药魔方","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602322575?lang=zh_cn&edition=full","pubTime":"2026-01-09 17:43","pubTimestamp":1767951793,"startTime":"0","endTime":"0","summary":"1月9日，致力于开发细胞外蛋白降解剂的EpiBiologics宣布完成1.07亿美元B轮融资，本轮融资由Google Ventures及Johnson & Johnson Innovation领投，Novartis Venture Fund等新投资者及Polaris Partners等现有投资者跟投。TrainTAC利用广泛的内化受体将膜蛋白和可溶性细胞外蛋白转运到溶酶体进行降解。EpiBiologics正在基于EpiTAC开发first-in-class及best-in-class靶向疗法，涉及肿瘤、免疫疾病等领域。在2025年AACR大会上，公司首次公布了c-Met EpiTAC双特异性抗体降解剂的临床前数据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109183655a706f830&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109183655a706f830&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1280957306.USD","IE00BMPRXR70.SGD","LU0312595415.SGD","LU0127658192.USD","LU0683600562.USD","LU0496365809.HKD","LU1674673428.USD","IE00BJT1NW94.SGD","LU1235294995.USD","LU0719512351.SGD","LU1267930573.SGD","LU1989764748.USD","LU0175139822.USD","LU1804176565.USD","LU2168564149.EUR","IE00BJJMRX11.SGD","LU0149725797.USD","LU1267930730.SGD","LU0096364046.USD","LU2244417387.USD","LU0354030511.USD","LU0964807845.USD","LU0170899867.USD","LU1791710582.SGD","LU0868494617.USD","IE00BFSS7M15.SGD","LU1839511570.USD","LU1316542783.SGD","BK4598","LU1244550221.USD","LU1496350502.SGD","LU2463028550.USD","IE00B42XCP33.USD","IE00B4JS1V06.HKD","LU1868836757.USD","USJW.SI","IE00BDGV0183.EUR","BK4587","LU0210528500.USD","IE00BN8TJ469.HKD","LU0203201768.USD","LU0068578508.USD","LU0323591593.USD","LU0823421416.USD","LU1069347547.HKD","SGXZ81514606.USD","LU2764263039.SGD","LU0225283273.USD","LU0345770993.USD","LU1732799900.SGD","IE0001KFT4U8.USD","LU2129689605.HKD","LU2357305700.SGD","LU1244550577.SGD","LU0795875169.SGD","IE00BGHQF631.EUR","LU0130103400.USD","SG9999002232.USD","IE00BHPRN162.USD","LU0432979614.USD","IE0004091025.USD","LU0417517546.SGD","LU2896262040.SGD","LU2505996509.AUD","LU2065169927.USD","LU2237443549.SGD","LU0557290698.USD","LU0456855351.SGD","LU0215105999.USD","SG9999002224.SGD","LU0889566641.SGD","LU2456880835.USD","LU0738911758.USD","LU1032466523.USD","IE00BJJMRY28.SGD","LU2097829019.USD","LU1720051017.SGD","IE00B4R5TH58.HKD","LU1894683348.USD","LU2487616109.SGD","LU0130518102.USD","LU0187121727.USD","IE0009355771.USD","LU0211326755.USD","LU0080751232.USD","LU1803068979.SGD","LU1935042991.SGD","LU0061475181.USD","LU1221951129.SGD","LU2471134523.USD","LU0882574139.USD","LU2087625088.SGD","LU1642822529.SGD","LU0348723411.USD","IE00BKDWB100.SGD","BK4504","LU0949170772.SGD","LU0052756011.USD","LU0211328371.USD","LU0128525689.USD","LU2275660780.HKD","LU0308772762.SGD","LU1951198990.SGD","LU2361044949.HKD","IE0004445015.USD","IE00BQXX3F31.USD","LU0316494557.USD","GOOGL","LU1323610961.USD","LU2764263203.CNY","LU0203345920.USD","LU0640476718.USD","LU0792757196.USD","LU1670627923.USD","BK4578","LU2092627202.USD","LU2430703251.USD","LU0211326839.USD","LU0823434583.USD","LU1814569148.SGD","LU2404859667.USD","LU0208291251.USD","IE00BZ1G4Q59.USD","LU2552382215.SGD","LU1066051225.USD","LU1162221912.USD","LU0994945656.USD","LU2750360641.GBP","LU2404859741.USD","BK4503","LU2089984988.USD","LU0354030438.USD","IE00BKPKM429.USD","LU1153585028.USD","LU0477156953.USD","LU1023059063.AUD","LU2213496289.HKD","LU1670628061.USD","LU2125154778.USD","IE00BJTD4N35.SGD","LU2125154935.USD","LU0211331839.USD","LU2077746001.SGD","LU0823434740.USD","LU1868836914.USD","SG9999015978.USD","LU2264538146.SGD","SG9999017495.SGD","LU0820561818.USD","LU0985489474.SGD","LU2028103732.USD","LU0082616367.USD","LU1057294990.SGD","LU2360106780.USD","BK4592","LU0528227936.USD","LU2097344431.USD","LU2065170008.USD","LU0444973449.USD","LU0314106906.USD","LU0708994859.HKD","BK4077","IE00B19Z3581.USD","IE00BZ199S13.USD","LU0965508806.USD","LU0476273544.USD","LU1221951046.USD","LU0310800965.SGD","LU1066053197.SGD","LU2360032135.SGD","IE00BBT3K403.USD","LU0251132253.USD","LU0130102774.USD","IE00BLSP4239.USD","LU0912757837.SGD","SG9999014898.SGD","LU0672654240.SGD","SG9999018865.SGD","LU1935043536.SGD","LU2326559502.SGD","BK4548","LU0553294199.USD","LU1043141396.HKD","LU2023251221.USD","IE00B2B36J28.USD","LU0820562030.AUD","LU0058720904.USD","LU2471134952.CNY","LU2764262908.HKD","LU2129689431.USD","LU1551013425.SGD","BK4585","LU1066051498.USD","LU1303367103.USD","LU1934455863.HKD","IE00BK4W5M84.HKD","LU0342679015.USD","IE00BYQQ9H92.USD","BK4568","LU0070302665.USD","SG9999015952.SGD","LU0690374615.EUR","LU1629891620.HKD","LU2552382132.HKD","LU0289739699.SGD","LU2756315664.SGD","LU0106261372.USD","LU0256863811.USD","LU1852331112.SGD","LU1035775433.USD","LU2168564495.EUR","LU0122379950.USD","LU2054465674.USD","LU1868837136.USD","LU0203202063.USD","IE00BN29S564.USD","IE00B5949003.HKD","IE00B775H168.HKD","LU0787776722.HKD","IE000M9KFDE8.USD","SG9999015986.USD","SGXZ51526630.SGD","LU1823568750.SGD","LU1935043023.USD","LU1732800096.USD","LU0056508442.USD","LU0158827781.USD","LU0061474705.USD","LU0006306889.USD","IE00BJJMRZ35.SGD","IE0009356076.USD","LU1201861165.SGD","LU2065171402.SGD","LU2746668461.USD","BK4514","LU1267930813.SGD","LU2602419157.SGD","LU2430703178.SGD","SG9999014914.USD","BK4533","LU0477156797.USD","LU0345769631.USD","LU0345770308.USD","LU0965509010.AUD","LU0957791311.USD","IE0034235188.USD","LU0784384876.USD","IE0002270589.USD","LU0320765059.SGD","LU0642271901.SGD","IE00B3S45H60.SGD","LU0426412945.USD","LU2023250504.SGD","BK4534","IE00B19Z3B42.SGD","LU1116320737.USD","LU0889565833.HKD","LU0426417589.USD","BK4550","LU0114720955.EUR","IE00BMPRXQ63.HKD","LU0276348264.USD","LU2097344357.USD","LU0097036916.USD","LU0251142724.SGD","LU0211327993.USD","LU0310800379.SGD","IE00BVYPNW00.USD","LU2065171311.SGD","LU2471134796.USD","BK4581","LU1496350171.SGD","LU1435385759.SGD","LU0784385840.USD","LU2237443978.SGD","LU0985320562.USD","LU2403377893.USD","LU0124676726.USD","LU0029864427.USD","BK4612","LU1691799644.USD","LU1585245621.USD","LU2720916845.USD","LU1923623000.USD","LU0433182093.SGD","IE00B1XK9C88.USD","LU2087621335.USD","LU1489326972.SGD","LU0234572021.USD","LU1551013342.USD","LU2098885051.SGD","LU0345768740.USD","LU0061474960.USD","LU0784383803.USD","LU2746668974.SGD","LU0198837287.USD","LU1880398471.USD","LU0942090050.USD","SG9999014880.SGD","LU2242649171.HKD","LU2271345857.HKD","LU2430703095.HKD","LU0345768153.USD","NVS","LU0788109477.HKD","LU1119994496.HKD","LU1201861249.SGD","IE00B775SV38.USD","BK4559","LU2471134879.HKD","LU1037948541.HKD","LU0878866978.SGD","LU0353189680.USD","LU0070217475.USD","IE00B19Z9505.USD","BK4507","LU2237443382.USD","LU1935042215.USD","LU1043141123.HKD","LU1116320901.HKD","LU0943347566.SGD","LU1366192091.USD","LU1868837300.USD","LU2023250330.USD","LU0708995401.HKD","LU0690374961.EUR","LU0320765489.SGD","LU1267930490.SGD","JNJ","BK4574","LU2237438978.USD","LU1037948897.HKD","LU2247934214.USD","IE00BQXX3C00.GBP","LU1917777945.USD","LU0094547139.USD","IE00B19Z8W00.USD","LU1084165304.USD","LU0256863902.USD","IE00BQXX3D17.EUR","LU0158827948.USD","LU2458330169.SGD","LU2108987350.USD","LU1430594728.SGD","LU2237443622.USD","BK4573","LU0107464264.USD","LU1267930227.SGD","LU2250418816.HKD","LU2417539215.USD","BK4525","LU2347655156.SGD","SGXZ99366536.SGD","LU1988902786.USD","LU1720051108.HKD","LU0210533765.USD","LU2552382058.USD","LU0048573561.USD","BK4576","LU2462157665.USD","LU2168564065.EUR","LU0353189763.USD","BK4566","LU1032955483.USD","LU0861579265.USD","BK4538","LU0820561909.HKD","IE0002141913.USD","LU2063271972.USD","LU1244550494.USD","LU0320765646.SGD","IE00BKVL7J92.USD","GOOG","LU1571399168.USD","LU1674673691.USD","SG9999018857.SGD","IE00BWXC8680.SGD","LU0784385170.HKD","IE00BVYPNV92.GBP","LU1934455194.USD","SG9999001077.SGD","LU0289960550.SGD","LU0302445910.USD","LU2211815571.USD","LU0444971666.USD","LU0648001328.SGD","LU2491049909.HKD","BK4543","LU2361044865.SGD","LU0882574055.USD","LU1232071149.USD","LU1145028129.USD","LU0048584097.USD","LU2023250843.SGD","LU1935042488.USD","SG9999014906.USD","LU2242650005.HKD","LU2361045086.USD","LU2505996681.GBP","IE00BMPRXN33.USD","LU1003077747.HKD","LU1914381329.SGD","BK4532","LU1127390331.HKD","LU0130517989.USD","LU0072462426.USD","LU0976567544.SGD","LU1301847155.USD","LU1066051811.HKD","LU2362541273.HKD","IE00BFMHRM44.USD","IE00B19Z8X17.USD","LU0289941410.SGD","LU2191332357.HKD","SGXZ31699556.SGD","LU0823421333.USD","SG9999001440.SGD","LU1366333091.USD","LU0267386448.USD","LU0210536198.USD","LU0154236417.USD","LU1989764664.SGD","LU2129689514.USD","LU1815336760.USD","IE0004445239.USD","LU0096362180.USD","BK4554","LU2236285917.USD","LU0098860793.USD","LU2237443465.HKD","LU0949170426.SGD","IE00B7SZLL34.SGD","LU1035773651.USD","LU1061106388.HKD","LU1868836591.USD","IE00BFXG1179.USD","LU0238689110.USD","LU2860962120.EUR","LU2468319806.SGD","IE00BJTD4V19.USD","IE00B5TLWC47.USD","IE0004086264.USD","LU0648000940.SGD","LU1974910355.USD","LU0786609619.USD","LU2168564222.USD","LU1633808545.USD","LU2592432038.USD","LU0868494708.USD","LU0345774391.USD","LU2265009873.SGD","IE00BFXG0V08.USD","LU0795875086.SGD","LU0265550946.USD","LU0234570918.USD","LU2092937148.SGD","LU1929549753.HKD","LU2420271590.USD","LU0265550359.USD","LU0689626769.HKD","IE00B3T34201.USD","LU1951200564.SGD","LU1880398554.USD","SG9999000418.SGD","LU2491050154.USD","BK4561","BK4527","LU0724617625.USD","LU1778281490.HKD","LU2168563687.JPY","LU2111349929.HKD","LU0742534661.SGD","LU0494093205.USD","LU0314104364.USD","SG9999015945.SGD","IE00BSNM7G36.USD","LU2461242641.AUD","GB00B4LPDJ14.GBP","LU2362540622.SGD","LU2756315318.SGD","LU2491050071.SGD","LU0053666078.USD","LU0077335932.USD","LU1261432733.SGD","IE00BFSS8Q28.SGD","LU1121112475.USD","LU1548497426.USD","LU2750360997.AUD","LU0965509101.SGD","LU1803068623.USD","IE00B7KXQ091.USD","LU1046421795.USD","LU0251131958.USD","LU0157215616.USD","LU0345769128.USD","IE00BFTCPJ56.SGD","BK4579","LU1064131342.USD","LU0203347892.USD","LU2133065610.SGD","LU2458330243.SGD","LU1069344957.HKD","LU2237443895.HKD","IE00BLSP4452.SGD","LU1429558221.USD","LU0545039389.USD","IE0034235303.USD","LU0011850046.USD","LU0466842654.USD","BK4588","LU1059921491.USD","LU1718418525.SGD","BK4602","LU0965509283.SGD","LU1894683264.USD","LU1196500208.SGD","IE00B3PB1722.GBP","LU1074936037.SGD","LU2106854487.HKD","LU0957808578.USD","LU2381873111.SGD","LU1791710400.SGD","LU2543165471.USD","LU2089283258.USD","LU1699723380.USD","LU0079474960.USD","LU2089284900.SGD","LU0109391861.USD","IE00BJLML261.HKD","LU0109392836.USD","IE0005OL40V9.USD","LU2362541513.USD","LU0980610538.SGD","BK4007","BK4553","LU1506573853.SGD","LU0345774631.USD","IE00BK4W5L77.USD","LU0661504455.SGD","IE00B1BXHZ80.USD","LU0310799852.SGD","LU0689472784.USD","LU0128525929.USD","LU1934455277.USD","LU2286300806.USD","LU1815333072.USD","LU2112291526.USD","GB00B4QBRK32.GBP"],"gpt_icon":1},{"id":"2602006340","title":"千亿美元“专利悬崖”逼近！美股制药巨头瞄准收购新药，中小盘生物科技股迎来“超级溢价”投资盛宴？","url":"https://stock-news.laohu8.com/highlight/detail?id=2602006340","media":"智通财经","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602006340?lang=zh_cn&edition=full","pubTime":"2026-01-09 16:00","pubTimestamp":1767945631,"startTime":"0","endTime":"0","summary":"而多种因素共同促成了生物科技并购的爆发式增长。一些全球最畅销的药物正面临在关键地区失去专利保护的风险，这被业内称为“专利悬崖”。据计算，到2032年，畅销品牌专利保护期的丧失将造成至少1739亿美元的年销售额损失。生物科技板块近几年经历繁荣、衰退，然后又是繁荣新冠疫情期间，生物科技行业迅速成为投资者的热门之选。Loren表示，一系列利好数据也推高了生物科技股的估值。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1390856.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":"美股制药巨头瞄准收购新药，中小盘生物科技股迎来“超级溢价”投资盛宴？","news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["MRK","BMY","GSK","NVO","AZN","NVS","PFE","LLY"],"gpt_icon":1},{"id":"2592192144","title":"特朗普标榜“大胜”：九大药企达成降价协议换取三年关税豁免","url":"https://stock-news.laohu8.com/highlight/detail?id=2592192144","media":"华尔街见闻","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592192144?lang=zh_cn&edition=full","pubTime":"2025-12-20 08:48","pubTimestamp":1766191729,"startTime":"0","endTime":"0","summary":"默沙东、诺华、葛兰素史克等九家药企签署协议后，特朗普称，今夏被政府盯上的17家药企中已有14家同意“大幅”降价。美商务部长暗示，剩余三家将在年末假期后宣布类似的协议。","market":"fut","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":{"source":null,"url":"https://wallstreetcn.com/articles/3761750","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3761750","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"特朗普标榜“大胜”：九大药企达成降价协议换取三年关税豁免","news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRK","NVS","GSK"],"gpt_icon":1},{"id":"2592139231","title":"默沙东(MRK.US)、施贵宝(BMY.US)等多家药企同意下调美国药价 以换取特朗普政府关税豁免和政策支持","url":"https://stock-news.laohu8.com/highlight/detail?id=2592139231","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592139231?lang=zh_cn&edition=full","pubTime":"2025-12-20 07:00","pubTimestamp":1766185200,"startTime":"0","endTime":"0","summary":"美国总统特朗普推动将美国药价与海外低价市场挂钩之际，多家美国及欧洲大型制药企业近日与白宫达成协议，同意自愿下调在美销售的药品价格，以换取关税豁免和政策支持。在此次协议中，最受市场关注的是施贵宝的让利承诺。特朗普在周五的公开活动上表示，今年7月他致信要求降价的17家大型制药企业中，已有14家同意大幅下调药价。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"2acbaf8fbf691a451fa9ea170ee88816","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1384042.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0265550359.USD","MRK","SG9999001176.SGD","LU1989772923.USD","GILD","LU2242646821.SGD","GSK","LU0477156953.USD","LU1116320737.USD","IE00B4R5TH58.HKD","LU0061475181.USD","LU1585245621.USD","LU2089984988.USD","LU1116320901.HKD","LU1093756168.USD","LU1670711040.USD","LU0985320562.USD","LU1699723380.USD","04332","IE00BLSP4452.SGD","LU1093756325.SGD","LU0098860793.USD","LU2125154935.USD","LU2361044949.HKD","SG9999015341.SGD","LU0306806265.USD","BK4550","LU1989771016.USD","LU1201861249.SGD","LU0861579265.USD","LU0058720904.USD","LU1037948897.HKD","LU1291159041.SGD","LU2361044865.SGD","IE00BN8TJ469.HKD","LU1069347547.HKD","LU1670711123.USD","LU1868836914.USD","BK4516","LU0321505439.SGD","SG9999014542.SGD","LU1934455277.USD","LU1261432733.SGD","LU0211331839.USD","LU0306807586.USD","LU0320765646.SGD","LU0114720955.EUR","AZN","LU1868837300.USD","LU1934455194.USD","IE00B2B36J28.USD","LU0456855351.SGD","IE00BBT3K403.USD","LU2360032135.SGD","BK4007","LU0265550946.USD","IE00B1BXHZ80.USD","IE00BFXG1179.USD","LU0225284248.USD","LU0106261372.USD","SG9999014575.USD","LU0267386448.USD","LU0965509283.SGD","IE000M9KFDE8.USD","ABBV","LU1074936037.SGD","LU1718418525.SGD","LU1323610961.USD","LU1917777945.USD","LU1929549753.HKD","LU0237698245.USD","LU2242652126.USD","LU1023059063.AUD","LU0203347892.USD","LU2023250504.SGD","IE00BLSP4239.USD","LU2125154778.USD","SG9999014567.USD","SG9999002224.SGD","BK4534","IE00BJJMRZ35.SGD","LU1066051225.USD","SG9999013999.USD","LU2468319806.SGD","LU2324357040.USD","LU2023250843.SGD","LU0320765489.SGD","LU1989772840.SGD","LU1162221912.USD","LU1868836757.USD","LU1061106388.HKD","LU0130517989.USD","BK4559","SG9999001440.SGD","LU0965509101.SGD","LU0234572021.USD","LU0238689110.USD","LU1670710588.SGD","ROG","LU1983299246.USD","SNY","LU1066053197.SGD","LU1974910355.USD","LU1066051498.USD","BK4588","LU0006306889.USD","LU1670710661.SGD","LU0096364046.USD","LU0266013472.USD","LU0208291251.USD","LU0130102774.USD","LU0289739699.SGD","LU0648001328.SGD","SG9999001176.USD","LU1066051811.HKD","LU0321505868.SGD","LU1430594728.SGD","BK4532","BMY","LU0965509010.AUD","LU0070302665.USD","AMGN","IE0002141913.USD","LU0122379950.USD","LU1057294990.SGD","IE00BFTCPJ56.SGD","LU1571399168.USD","IE00BJT1NW94.SGD","SGXZ57979304.SGD","IE0009355771.USD","LU0965508806.USD","REGN","SG9999014559.SGD","LU0225771236.USD","LU0985481810.HKD","LU2106854487.HKD","BK4533","LU0882574055.USD","LU1868837136.USD","LU1868836591.USD","BK4581","LU0868494617.USD","NVS","LU1035773651.USD","LU0203345920.USD","LU1037948541.HKD","SG9999002232.USD","LU2361045086.USD","LU1934455863.HKD","LU2133065610.SGD","LU1941712264.USD","LU1941712348.USD","BK4585","IE00BSNM7G36.USD","LU2112291526.USD","LU1032466523.USD","SG9999015358.SGD","LU2461242641.AUD","JNJ","LU0980610538.SGD"],"gpt_icon":1},{"id":"1190397083","title":"美国官员称与安进、施贵宝、罗氏旗下基因泰克、吉利德、葛兰素史克、默沙东、诺华、赛诺菲和博瑞诺的交易","url":"https://stock-news.laohu8.com/highlight/detail?id=1190397083","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1190397083?lang=zh_cn&edition=full","pubTime":"2025-12-20 03:22","pubTimestamp":1766172127,"startTime":"0","endTime":"0","summary":"美国官员称与安进、施贵宝、罗氏旗下基因泰克、吉利德、葛兰素史克、默沙东、诺华、赛诺菲和博瑞诺的交易","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1670756490.USD","LU0203347892.USD","LU1261432733.SGD","LU1670711040.USD","LU1868836591.USD","LU0130517989.USD","LU1400636574.HKD","LU0456855351.SGD","LU1202635105.USD","SNY","LU0109981661.USD","LU1037948541.HKD","IE00BKVL7J92.USD","LU1989772923.USD","LU0122379950.USD","BK4516","LU1974910355.USD","LU0006306889.USD","LU1035773651.USD","LU1989771016.USD","IE00BLSP4452.SGD","IE00BFTCPJ56.SGD","LU0965508806.USD","LU0985481810.HKD","LU2106854487.HKD","LU1481599808.USD","LU2360032135.SGD","IE00B19Z3B42.SGD","LU2361045086.USD","LU0289739699.SGD","LU0320765646.SGD","LU1934455277.USD","LU1064927863.SGD","LU1430594728.SGD","LU0114720955.EUR","AMGN","IE00BZ1G4Q59.USD","LU1670711123.USD","IE0009355771.USD","NVS","LU2324357040.USD","SG9999014567.USD","LU2461242641.AUD","LU2133065610.SGD","LU0971552673.USD","LU0265550946.USD","LU0861579265.USD","LU1093756168.USD","LU1934455863.HKD","LU0320765489.SGD","LU1098665638.USD","LU1699723380.USD","LU0648001328.SGD","LU0965509010.AUD","LU2242646821.SGD","IE00BFXG1179.USD","BK4568","LU0980610538.SGD","LU0061475181.USD","LU2112291526.USD","LU1645745479.HKD","LU2125154935.USD","LU1069347547.HKD","LU1839511570.USD","BK4007","IE00BLSP4239.USD","LU0208291251.USD","BK4559","LU1718418525.SGD","IE00B1BXHZ80.USD","SG9999013999.USD","LU0070302665.USD","IE00B7SZLL34.SGD","LU0211331839.USD","LU0161305163.EUR","RHHBY","BMY","LU0882574055.USD","LU1162221912.USD","LU1670710588.SGD","LU1868836914.USD","LU0225771236.USD","IE00BJT1NW94.SGD","LU0058720904.USD","LU1093756325.SGD","BK4578","LU1400636491.USD","LU1585245621.USD","LU0225284248.USD","BK4581","LU1674673691.USD","IE00B2B36J28.USD","LU1941712264.USD","LU0203345920.USD","LU1571399168.USD","LU1481600234.SGD","BK4532","LU1228905540.USD","LU1074936037.SGD","SG9999002224.SGD","IE00B3T34201.USD","BK4534","LU0868494617.USD","SG9999001440.SGD","LU1116320737.USD","LU1400636657.SGD","LU0234570918.USD","LU0306806265.USD","LU0130102774.USD","IE00BQJZX424.USD","LU0237698245.USD","SGXZ57979304.SGD","LU0234572021.USD","LU0321505439.SGD","LU2242652126.USD","LU0096364046.USD","LU1487256676.USD","IE0002270589.USD","IE00BJJMRZ35.SGD","IE00BWDBJ516.SGD","IE00BBT3K403.USD","LU0965509283.SGD","LU1323610961.USD","SG9999015978.USD","IE00B4R5TH58.HKD","BK4533","LU0545562505.USD","LU0575583348.USD","LU1015430645.USD","BK4566","LU2361044949.HKD","LU0098860793.USD","LU0266013472.USD","LU1868837136.USD","GSK","SG9999014575.USD","LU0320765992.SGD","SG9999014542.SGD","LU2125154778.USD","LU0965509101.SGD","LU0971552830.HKD","LU1066051811.HKD","SG9999002232.USD","LU1309081286.SGD","IE000M9KFDE8.USD","LU1201861249.SGD","LU2023250504.SGD","GILD","LU1674673428.USD","LU1302929846.USD","LU1934455194.USD","IE00BSNM7G36.USD","LU2087621335.USD","BK4583","LU0823416689.USD","SG9999015945.SGD","SG9999015986.USD","LU1116320901.HKD","LU1929549753.HKD","IE00B19Z3581.USD","LU0321505868.SGD","LU1778281490.HKD","LU0985320562.USD","LU1023059063.AUD","LU1061106388.HKD","04332","BK4550","LU0109394709.USD","LU0265550359.USD","LU1066051225.USD","LU1057294990.SGD","LU2089984988.USD","LU1066051498.USD","LU1989772840.SGD","LU2023250843.SGD","LU1037948897.HKD","BK4585","LU1032466523.USD","BK4139","LU1228905037.USD","MRK","SG9999015341.SGD","BK4588","BK5011","LU1941712348.USD","BIIB","LU0238689110.USD","LU1917777945.USD","LU0106261372.USD","LU0306807586.USD","LU2468319806.SGD","LU1291159041.SGD","IE0002141913.USD","SG9999001176.SGD","SG9999015358.SGD","LU1868837300.USD","LU1983299246.USD","LU1868836757.USD","BK4599","LU0267386448.USD","IE0034235071.USD","LU1066053197.SGD","LU1670710661.SGD","SG9999014559.SGD","SG9999015952.SGD","LU0889565916.HKD","LU1046248800.SGD","SG9999001176.USD","LU1035777561.USD","IE00BN8TJ469.HKD","LU2361044865.SGD","LU0477156953.USD"],"gpt_icon":0},{"id":"2591649704","title":"中国同辐(01763)附属原子高科与诺华公司签署商业合作协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2591649704","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591649704?lang=zh_cn&edition=full","pubTime":"2025-12-15 21:15","pubTimestamp":1765804518,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国同辐(01763)发布公告，本公司附属公司原子高科股份有限公司(原子高科)与诺华医药科技(浙江)有限公司(诺华公司)正式签署派威妥®(镥[177Lu]特昔维匹肽注射液)商业合作协议(商业合作协议)。派威妥® 是国内首个且目前唯一获批的靶向PSMA的放射配体疗法药物，主要用于治疗晚期前列腺癌，未来将为患者提供延长生命并改善生活质量的全新核药治疗方案。此次签约开启了双方在创新核药产品派威妥®方面的战略合作，原子高科将凭藉在放射性药物领域的多年合规运营经验，与诺华公司强强联合，为医疗机构和患者提供定制化的派威妥®产品供应与解决方案，以惠及更多的患者。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1381802.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0070302665.USD","NVS","LU0211331839.USD","LU0320765489.SGD","IE00B2B36J28.USD","BK4532","LU0208291251.USD","BK4588","IE00B4R5TH58.HKD","BK4007","BK4578","IE0009355771.USD","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","IE0002141913.USD","BK4585","IE00BJJMRZ35.SGD","BK1222","01763"],"gpt_icon":0},{"id":"2590311199","title":"美股异动丨诺华制药盘前涨近2%，布局过敏性疾病新靶点","url":"https://stock-news.laohu8.com/highlight/detail?id=2590311199","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590311199?lang=zh_cn&edition=full","pubTime":"2025-12-09 17:27","pubTimestamp":1765272424,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["IE0002141913.USD","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","IE0009355771.USD","LU0211331839.USD","IE00B2B36J28.USD","BK1574","IE00B4R5TH58.HKD","BK4007","NVS","BK4588","01477","LU0208291251.USD","BK4585","BK1191","IE00BJJMRZ35.SGD","BK4578","BK4532","LU0320765489.SGD","LU0070302665.USD"],"gpt_icon":0},{"id":"2590390096","title":"诺华制药(NVS.US)17亿美元押注英国AI药企 布局过敏性疾病新靶点","url":"https://stock-news.laohu8.com/highlight/detail?id=2590390096","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590390096?lang=zh_cn&edition=full","pubTime":"2025-12-09 15:03","pubTimestamp":1765263792,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，诺华制药将支付英国生物技术公司 Relation Therapeutics Ltd. 高达 17 亿美元，以帮助寻找治疗过敏性疾病的药物靶点。今年早些时候，诺华制药同意以 14 亿美元收购 Tourmaline Bio 公司，从而获得一种有望减轻全身性炎症的治疗方法。该公司还同意以最高 17 亿美元的价格收购美国生物技术公司 Regulus Therapeutics，并通过收购美国生物技术公司 Anthos Therapeutics 进一步丰富其心脏病学产品组合，以获得一种预防中风的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1379249.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK1574","BK4585","BK4007","IE00B2B36J28.USD","IE0002141913.USD","BK4578","LU0208291251.USD","01477","LU0320765489.SGD","IE00BFTCPJ56.SGD","LU0211331839.USD","NVS","BK4532","IE00BJJMRZ35.SGD","IE0009355771.USD","IE00B4R5TH58.HKD","BK4588","IE00BJT1NW94.SGD","LU0070302665.USD"],"gpt_icon":0},{"id":"2588013596","title":"大摩：将诺华制药目标价上调至115瑞士法郎","url":"https://stock-news.laohu8.com/highlight/detail?id=2588013596","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588013596?lang=zh_cn&edition=full","pubTime":"2025-12-03 15:17","pubTimestamp":1764746221,"startTime":"0","endTime":"0","summary":"摩根士丹利：将诺华制药目标价从110瑞士法郎上调至115瑞士法郎。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20251203/31841213.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["01477","NVS"],"gpt_icon":0},{"id":"2586284416","title":"诺华慢性自发性荨麻疹创新药物瑞普多（瑞米布替尼片）在华获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2586284416","media":"南方财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586284416?lang=zh_cn&edition=full","pubTime":"2025-11-26 10:56","pubTimestamp":1764125818,"startTime":"0","endTime":"0","summary":"南方财经11月26日电，诺华公司今日宣布，其创新药物瑞普多?（瑞米布替尼片）获得国家药品监督管理局批准，适用于H1抗组胺药控制不充分的成人慢性自发性荨麻疹（CSU）患者。瑞米布替尼片的获批有望构建CSU治疗新格局，开启口服小分子靶向治疗*新篇章，为中国超过千万长期饱受CSU困扰的患者带来治疗新选择。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511263575225572.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1574","IE0002141913.USD","BK4578","LU0211331839.USD","NVS","IE0009355771.USD","BK4585","BK4588","06978","BK4007","LU0208291251.USD","IE00BJT1NW94.SGD","BK1161","IE00BFTCPJ56.SGD","LU0320765489.SGD","BK4532","IE00B2B36J28.USD","LU0070302665.USD","IE00B4R5TH58.HKD","159992","IE00BJJMRZ35.SGD"],"gpt_icon":0},{"id":"2586429344","title":"诺华计划2027年底前在瑞士裁员550人","url":"https://stock-news.laohu8.com/highlight/detail?id=2586429344","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586429344?lang=zh_cn&edition=full","pubTime":"2025-11-25 18:02","pubTimestamp":1764064931,"startTime":"0","endTime":"0","summary":null,"market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["NVS","BK4532","IE00BJT1NW94.SGD","BK4578","IE0009355771.USD","LU0211331839.USD","LU0320765489.SGD","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","BK4588","BK4585","IE0002141913.USD","LU0208291251.USD","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","LU0070302665.USD","BK4007"],"gpt_icon":0},{"id":"2586449251","title":"诺华中国回应解散县域团队传闻","url":"https://stock-news.laohu8.com/highlight/detail?id=2586449251","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586449251?lang=zh_cn&edition=full","pubTime":"2025-11-25 13:44","pubTimestamp":1764049489,"startTime":"0","endTime":"0","summary":"南方财经11月25日电，据界面新闻，有消息称诺华中国区县域团队将整体解散，最后工作日定为12月31日。对此，诺华回应称，为持续服务中国县域医疗市场，自2026年1月1日起，诺华公司将对县域业务运营模式进行调整。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511253574099255.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4578","BK4588","IE0009355771.USD","BK4585","NVS","IE00BJT1NW94.SGD","IE0002141913.USD","IE00B2B36J28.USD","LU0211331839.USD","LU0320765489.SGD","BK4532","IE00BFTCPJ56.SGD","BK4007","LU0070302665.USD","IE00B4R5TH58.HKD","LU0208291251.USD","IE00BJJMRZ35.SGD"],"gpt_icon":0},{"id":"2586244925","title":"诺华同意收购RNA疗法创新企业Avidity Biosciences，以强化其后期阶段的神经科学管线","url":"https://stock-news.laohu8.com/highlight/detail?id=2586244925","media":"动脉网","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586244925?lang=zh_cn&edition=full","pubTime":"2025-11-25 12:36","pubTimestamp":1764045360,"startTime":"0","endTime":"0","summary":"诺华宣布收购RNA疗法企业Avidity Biosciences，收购将在Avidity分拆早期心脏疾病项目后进行。此次收购契合诺华深耕神经科学的战略，有望填补遗传性疾病治疗空白，扩展公司管线。Avidity项目包含潜在同类首创、处于临床试验后期阶段的疾病修饰疗法，适用于多种罕见神经肌肉疾病。基于诺华专业经验及商业化能力，此次收购有望打造行业领先研发管线，AOC平台将单抗组织特异性与寡核苷酸精准调控结合，有望改变疾病进程，对患者生活产生积极影响。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251125125311977ddcf7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251125125311977ddcf7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","LU0320765489.SGD","BK4588","IE0002141913.USD","IE00B4R5TH58.HKD","BK4139","BK4578","LU0211331839.USD","LU0208291251.USD","NVS","BK4532","IE00BJT1NW94.SGD","IE0009354923.USD","IE00B2B36J28.USD","RNA","IE00BFTCPJ56.SGD","BK4007","IE0009355771.USD","IE00BJJMRZ35.SGD","BK4585","LU0070302665.USD"],"gpt_icon":0},{"id":"2586416462","title":"美国FDA批准诺华基因疗法治疗罕见肌肉疾病","url":"https://stock-news.laohu8.com/highlight/detail?id=2586416462","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586416462?lang=zh_cn&edition=full","pubTime":"2025-11-25 07:46","pubTimestamp":1764028013,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU0211331839.USD","IE0002141913.USD","BK4578","LU0070302665.USD","BK4588","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","LU0320765489.SGD","BK4585","BK4007","IE0009355771.USD","LU0208291251.USD","NVS","BK4532","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","IE00B2B36J28.USD"],"gpt_icon":0},{"id":"2584013917","title":"诺华制药预计2030年销售增长至多6%，上调主要癌症药物销售预测","url":"https://stock-news.laohu8.com/highlight/detail?id=2584013917","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584013917?lang=zh_cn&edition=full","pubTime":"2025-11-20 20:33","pubTimestamp":1763642002,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4578","IE00BJT1NW94.SGD","BK4588","LU0208291251.USD","LU0320765489.SGD","BK4585","IE00BFTCPJ56.SGD","LU0211331839.USD","IE0009355771.USD","BK4532","IE00B4R5TH58.HKD","LU0070302665.USD","BK1191","BK4007","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","NVS","IE0002141913.USD","01477","BK1574"],"gpt_icon":0},{"id":"2584825041","title":"诺华(NVS)拟在美国北卡罗来纳州新建制造中心","url":"https://stock-news.laohu8.com/highlight/detail?id=2584825041","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584825041?lang=zh_cn&edition=full","pubTime":"2025-11-20 17:15","pubTimestamp":1763630119,"startTime":"0","endTime":"0","summary":"金吾财讯 | 瑞士诺华公司(NVS)表示，将扩大在美国北卡罗来纳州的业务，计划建立一个制造中心，作为未来五年在美国投资230亿美元基础设施计划的一部分。诺华指出，预计于2027年或2028年启用的新中心，将包括位于北卡罗来纳州达勒姆的两座新设施，用于生物制剂生产和无菌包装，以及位于莫里斯维尔的固体制剂生产及包装设施。","market":"hk","thumbnail":"https://static.szfiu.com/news/20210810/ZDhjMmEyODE0Mjk1MzY2MjA4.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/ZDhjMmEyODE0Mjk1MzY2MjA4.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"294640","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","BK4588","BK4578","LU0320765489.SGD","LU0211331839.USD","IE00BJJMRZ35.SGD","BK4007","LU0070302665.USD","IE0002141913.USD","IE00B2B36J28.USD","IE00BJT1NW94.SGD","LU0208291251.USD","BK4585","NVS","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","IE0009355771.USD"],"gpt_icon":0},{"id":"2584850381","title":"诺华制药(NVS.US)上调两大抗癌药销售峰值预测 预计推动2030年前营收年均增长5%-6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584850381","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584850381?lang=zh_cn&edition=full","pubTime":"2025-11-20 15:42","pubTimestamp":1763624526,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，诺华制药预计，到 2030 年，经汇率调整后的销售额将增长 5%至 6%。这得益于其抗癌药物 Kisqali 和 Scemblix 的营收预期将达到更高水平。这家制药公司上调了 Kisqali的峰值销售额预测，从之前的 80 亿美元上调至至少 100 亿美元。该公司表示，其八款最具潜力的获批药物每款的潜在销售峰值都在 30 亿至 100 亿美元之间。该公司曾表示，此次收购计划将使其 2024 至 2029 年的年销售额增长率预测提高到 6%，高于此前预期的 5%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1371531.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["NVS","01477"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.novartis.com","stockEarnings":[{"period":"1week","weight":0.0284},{"period":"1month","weight":0.0698},{"period":"3month","weight":0.0887},{"period":"6month","weight":0.1981},{"period":"1year","weight":0.4314},{"period":"ytd","weight":0.0287}],"compareEarnings":[{"period":"1week","weight":0.0108},{"period":"1month","weight":0.0197},{"period":"3month","weight":0.0497},{"period":"6month","weight":0.1136},{"period":"1year","weight":0.1975},{"period":"ytd","weight":0.0194}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Novartis AG于1996年2月29日在瑞士成立。该公司是一家创新药物公司，从事各种创新药物的研究、开发、制造、分销、营销和销售。该公司的宗旨是利用其科学专业知识寻找治疗和治愈疾病的新方法，重新构想医学，以改善和延长人们的生命。该公司的业务分为五个组织部门：生物医学研究、开发、运营和两个商业部门（美国和国际）。全球职能部门支持这些组织部门开展工作。该公司专注于四个具有强大增长潜力和大量未满足患者需求的核心治疗领域—心血管、肾脏和代谢；免疫学；神经科学；和肿瘤学。","yearOnYearQuotes":[{"month":1,"riseRate":0.423077,"avgChangeRate":-0.009798},{"month":2,"riseRate":0.44,"avgChangeRate":-0.010046},{"month":3,"riseRate":0.52,"avgChangeRate":0.001443},{"month":4,"riseRate":0.72,"avgChangeRate":0.018717},{"month":5,"riseRate":0.68,"avgChangeRate":0.009252},{"month":6,"riseRate":0.576923,"avgChangeRate":0.011998},{"month":7,"riseRate":0.692308,"avgChangeRate":0.011407},{"month":8,"riseRate":0.423077,"avgChangeRate":0.001152},{"month":9,"riseRate":0.692308,"avgChangeRate":0.009673},{"month":10,"riseRate":0.423077,"avgChangeRate":-0.013123},{"month":11,"riseRate":0.615385,"avgChangeRate":0.016411},{"month":12,"riseRate":0.692308,"avgChangeRate":0.020635}],"exchange":"NYSE","name":"诺华","nameEN":"Novartis AG"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"诺华(NVS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供诺华(NVS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"诺华,NVS,诺华股票,诺华股票老虎,诺华股票老虎国际,诺华行情,诺华股票行情,诺华股价,诺华股市,诺华股票价格,诺华股票交易,诺华股票购买,诺华股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"诺华(NVS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供诺华(NVS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}